Jäntti MH - Search Results

1

Transient receptor potential channels and their role in modulating radial glial-neuronal interaction: a signaling pathway involving mGluR5.

Louhivuori LM, Jansson L, Turunen PM, Jäntti MH, Nordström T, Louhivuori V, Åkerman KE. Louhivuori LM, et al. Among authors: jantti mh. Stem Cells Dev. 2015 Mar 15;24(6):701-13. doi: 10.1089/scd.2014.0209. Epub 2014 Dec 17. Stem Cells Dev. 2015. PMID: 25347706 Free PMC article.

2

Agonist ligand discrimination by the two orexin receptors depends on the expression system.

Putula J, Turunen PM, Jäntti MH, Ekholm ME, Kukkonen JP. Putula J, et al. Among authors: jantti mh. Neurosci Lett. 2011 Apr 20;494(1):57-60. doi: 10.1016/j.neulet.2011.02.055. Epub 2011 Mar 6. Neurosci Lett. 2011. PMID: 21362456

3

OX1 orexin/hypocretin receptor signaling through arachidonic acid and endocannabinoid release.

Turunen PM, Jäntti MH, Kukkonen JP. Turunen PM, et al. Among authors: jantti mh. Mol Pharmacol. 2012 Aug;82(2):156-67. doi: 10.1124/mol.112.078063. Epub 2012 May 1. Mol Pharmacol. 2012. PMID: 22550093

4

Autocrine endocannabinoid signaling through CB1 receptors potentiates OX1 orexin receptor signaling.

Jäntti MH, Putula J, Turunen PM, Näsman J, Reijonen S, Lindqvist C, Kukkonen JP. Jäntti MH, et al. Mol Pharmacol. 2013 Mar;83(3):621-32. doi: 10.1124/mol.112.080523. Epub 2012 Dec 11. Mol Pharmacol. 2013. PMID: 23233488

5

Protein Kinase C Activation as a Potential Therapeutic Strategy in Alzheimer's Disease: Is there a Role for Embryonic Lethal Abnormal Vision-like Proteins?

Talman V, Pascale A, Jäntti M, Amadio M, Tuominen RK. Talman V, et al. Basic Clin Pharmacol Toxicol. 2016 Aug;119(2):149-60. doi: 10.1111/bcpt.12581. Epub 2016 Apr 29. Basic Clin Pharmacol Toxicol. 2016. PMID: 27001133 Free article. Review.

6

Prolyl oligopeptidase inhibition by KYP-2407 increases alpha-synuclein fibril degradation in neuron-like cells.

Rostami J, Jäntti M, Cui H, Rinne MK, Kukkonen JP, Falk A, Erlandsson A, Myöhänen T. Rostami J, et al. Biomed Pharmacother. 2020 Nov;131:110788. doi: 10.1016/j.biopha.2020.110788. Epub 2020 Sep 25. Biomed Pharmacother. 2020. PMID: 33152946 Free article.

7

Prolyl oligopeptidase inhibition activates autophagy via protein phosphatase 2A.

Svarcbahs R, Jäntti M, Kilpeläinen T, Julku UH, Urvas L, Kivioja S, Norrbacka S, Myöhänen TT. Svarcbahs R, et al. Pharmacol Res. 2020 Jan;151:104558. doi: 10.1016/j.phrs.2019.104558. Epub 2019 Nov 20. Pharmacol Res. 2020. PMID: 31759088

8

OX1 orexin/hypocretin receptor activation of phospholipase D.

Jäntti MH, Putula J, Somerharju P, Frohman MA, Kukkonen JP. Jäntti MH, et al. Br J Pharmacol. 2012 Feb;165(4b):1109-23. doi: 10.1111/j.1476-5381.2011.01565.x. Br J Pharmacol. 2012. PMID: 21718304 Free PMC article.

9

Human orexin/hypocretin receptors form constitutive homo- and heteromeric complexes with each other and with human CB1 cannabinoid receptors.

Jäntti MH, Mandrika I, Kukkonen JP. Jäntti MH, et al. Biochem Biophys Res Commun. 2014 Mar 7;445(2):486-90. doi: 10.1016/j.bbrc.2014.02.026. Epub 2014 Feb 13. Biochem Biophys Res Commun. 2014. PMID: 24530395

10

Corrigendum to "Prolyl oligopeptidase inhibition by KYP-2407 increases alpha-synuclein fibril degradation in neuron-like cells" [Biomed. Pharmacother. 131 (2020) 110788].

Rostami J, Jäntti M, Cui H, Rinne MK, Kukkonen JP, Falk A, Erlandsson A, Myöhänen T. Rostami J, et al. Biomed Pharmacother. 2021 Jan;133:111019. doi: 10.1016/j.biopha.2020.111019. Epub 2020 Nov 24. Biomed Pharmacother. 2021. PMID: 33246737 Free article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

24 results

Search Page

Filters